Compare SUNB & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUNB | WST |
|---|---|---|
| Founded | 1947 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4B | 26.4B |
| IPO Year | 2025 | 2004 |
| Metric | SUNB | WST |
|---|---|---|
| Price | $75.88 | $381.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 17 |
| Target Price | $88.57 | ★ $412.88 |
| AVG Volume (30 Days) | ★ 3.6M | 416.7K |
| Earning Date | 09-09-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.57% | 0.23% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | 1.07 | ★ 4.07 |
| Revenue | ★ $11,154,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $8.51 | $9.79 |
| Revenue Next Year | $6.96 | $6.29 |
| P/E Ratio | ★ $71.24 | $94.03 |
| Revenue Growth | ★ 3.36 | 1.95 |
| 52 Week Low | $61.03 | $223.83 |
| 52 Week High | $86.68 | $386.00 |
| Indicator | SUNB | WST |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 63.36 |
| Support Level | $74.41 | $346.45 |
| Resistance Level | $76.99 | $383.29 |
| Average True Range (ATR) | 2.57 | 8.42 |
| MACD | 0.06 | 0.50 |
| Stochastic Oscillator | 47.50 | 82.63 |
Sunbelt Rentals (formerly UK-based Ashtead Group) is the number two equipment rental company in the US (11% market share), with a smaller presence in Canada and the UK. Sunbelt operates a rental fleet of just over $15 billion across a network of 1,200 stores in the US, nearly CAD 2 billion of fleet and 135 stores in Canada, and GBP 1.1 billion and 190 stores in the UK. The company has experienced rapid growth over the past decade as its customers increasingly turn to rental versus owning equipment outright. The general tool business has been augmented by the Specialty Rental business, which has grown to 30% of the mix. Revenue is now greater than 50% nonconstruction, with the remainder focused more directly on commercial construction.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.